122 related articles for article (PubMed ID: 3350054)
1. Thromboxane A2 and the development of hypertension in spontaneously hypertensive rats.
Stier CT; Itskovitz HD
Eur J Pharmacol; 1988 Jan; 146(1):129-35. PubMed ID: 3350054
[TBL] [Abstract][Full Text] [Related]
2. Delay of the initiation of hypertension in spontaneously hypertensive rats by CV-4151, a specific thromboxane A2 synthetase inhibitor.
Shibouta Y; Terashita Z; Inada Y; Nishikawa K
Eur J Pharmacol; 1985 Feb; 109(2):135-44. PubMed ID: 3922775
[TBL] [Abstract][Full Text] [Related]
3. Role of thromboxane in control of arterial pressure and renal function in young spontaneously hypertensive rats.
Grone HJ; Grippo RS; Arendshorst WJ; Dunn MJ
Am J Physiol; 1986 Mar; 250(3 Pt 2):F488-96. PubMed ID: 3953827
[TBL] [Abstract][Full Text] [Related]
4. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.
Gomi T; Ikeda T; Ishimitsu T; Uehara Y
Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692
[TBL] [Abstract][Full Text] [Related]
5. Enhanced generation of vascular thromboxane A2 in spontaneously hypertensive rats and its role in the rapid proliferation of vascular smooth muscle cells.
Ishimitsu T; Uehara Y; Ishii M; Sugimoto T
Am J Hypertens; 1988 Jul; 1(3 Pt 3):38S-40S. PubMed ID: 3415806
[TBL] [Abstract][Full Text] [Related]
6. Effects of thromboxane synthetase inhibitor (OKY-046) on placental blood flow, placental weight and fetal weight in normotensive and spontaneously hypertensive rats.
Furuhashi N; Tsujiei M; Kimura H; Nagae H; Yajima A
Gynecol Obstet Invest; 1993; 35(1):23-6. PubMed ID: 8449429
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane synthesis and blood pressure in spontaneously hypertensive rats.
Purkerson ML; Martin KJ; Yates J; Kissane JM; Klahr S
Hypertension; 1986 Dec; 8(12):1113-20. PubMed ID: 3793195
[TBL] [Abstract][Full Text] [Related]
8. Delayed hypotensive effect of the thromboxane A2/prostaglandin H2 receptor antagonist S-1452 in spontaneously hypertensive rats.
Sugimoto KI; Shiga T; Fujimura A
Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):594-600. PubMed ID: 10901388
[TBL] [Abstract][Full Text] [Related]
9. Changes in vascular wall production of prostacyclin and thromboxane A2 in spontaneously hypertensive rats during maturation and the concomitant development of hypertension.
Osanai T; Matsumura H; Kikuchi T; Minami O; Yokono Y; Akiba R; Eidou H; Konta A; Kanazawa T; Onodera K
Jpn Circ J; 1990 May; 54(5):507-14. PubMed ID: 2232114
[TBL] [Abstract][Full Text] [Related]
10. Role of renomedullary thromboxane A2 in development of doca-salt hypertension.
Osanai T; Kikuchi T; Yokono Y; Matsumura H; Minami O; Akiba R; Eidoh H; Konta A; Kanazawa T; Onodera K
Clin Exp Hypertens A; 1991; 13(2):159-88. PubMed ID: 2065462
[TBL] [Abstract][Full Text] [Related]
11. Role for thromboxane A2 from glomerular thrombi in nephropathy with type 2 diabetic rats.
Okumura M; Imanishi M; Okamura M; Hosoi M; Okada N; Konishi Y; Morikawa T; Miura K; Nakatani T; Fujii S
Life Sci; 2003 May; 72(24):2695-705. PubMed ID: 12679187
[TBL] [Abstract][Full Text] [Related]
12. Renal effects of pinane-thromboxane A2 and indomethacin in saline volume-expanded spontaneously hypertensive rats.
Shibouta Y; Terashita ZI; Inada Y; Kato K; Nishikawa K
Eur J Pharmacol; 1982 Nov; 85(1):51-9. PubMed ID: 7151863
[TBL] [Abstract][Full Text] [Related]
13. Role of the prostaglandin-thromboxane system in the development and maintenance of spontaneous hypertension in the rat.
Yasujima M; Abe K; Tanno M; Kohzuki M; Sato M; Omata K; Takeuchi K; Hagino T; Yoshinaga K
Agents Actions Suppl; 1987; 22():133-8. PubMed ID: 3124554
[TBL] [Abstract][Full Text] [Related]
14. Effects of ridogrel, a thromboxane synthase inhibitor and receptor antagonist, on blood pressure in the spontaneously hypertensive rat.
Quest DW; Wilson TW
Jpn J Pharmacol; 1998 Dec; 78(4):479-86. PubMed ID: 9920205
[TBL] [Abstract][Full Text] [Related]
15. [Roles of vascular and renal thromboxanes in the antihypertensive effects of alpha 1 adrenoceptor antagonists].
Takada S; Uehara Y; Hirawa N; Numabe A; Yagi S
Nihon Jinzo Gakkai Shi; 1989 Sep; 31(9):969-75. PubMed ID: 2573747
[TBL] [Abstract][Full Text] [Related]
16. Acute and chronic effects of synthetic atrial natriuretic factor on blood pressure and sodium excretion in spontaneously hypertensive rats.
Kohzuki M; Abe K; Yasujima M; Kasai Y; Kanazawa M; Sato M; Hiwatari M; Omata K; Kudo K; Takeuchi K
Tohoku J Exp Med; 1989 Mar; 157(3):279-88. PubMed ID: 2524909
[TBL] [Abstract][Full Text] [Related]
17. In vivo enhancement of platelet activating factor-induced prostacyclin production by OKY-046, a selective inhibitor of thromboxane A2 synthase.
Davenport NJ; Goldstein RE; Feuerstein GZ
J Cardiovasc Pharmacol; 1991 Apr; 17(4):641-6. PubMed ID: 1711633
[TBL] [Abstract][Full Text] [Related]
18. Role of prostaglandin I2 and thromboxane A2 in the regulation of blood pressure.
Osanai T
Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):677-85. PubMed ID: 2507811
[TBL] [Abstract][Full Text] [Related]
19. Effects of a selective thromboxane synthetase inhibitor OKY-046 on experimental diabetic nephropathy.
Hora K; Oguchi H; Furukawa T; Hora K; Tokunaga S
Nephron; 1990; 56(3):297-305. PubMed ID: 2077412
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure effects of thromboxane A2 blockade in spontaneously hypertensive rats.
Boussairi EH; Sacquet J; Benzoni D; Sassard J
Clin Exp Pharmacol Physiol; 1993 Nov; 20(11):679-87. PubMed ID: 8306513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
